These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17087245)

  • 1. [Low molecular-weight heparin (clexane) in the prevention of thrombotic events in patients with malignancies].
    Somonova OV; Madzhuga AV; Elizarova AL; Sel'chuk VIu; Zubrikhina GN; Bokhian AIu
    Klin Lab Diagn; 2006 Aug; (8):31-3. PubMed ID: 17087245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of Clexane (low-molecular-weight heparin) on the hemostatic system and on the incidence of postoperative thrombotic complications in gynecological cancer patients].
    Madzhuga AV; Somonova OV; Kononenko LP; Gorobets ES; Elizarova AL; Astakhova VM
    Anesteziol Reanimatol; 2000; (2):54-6. PubMed ID: 10833839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enoxaparin for the prevention of post surgical pulmonary embolism].
    Xia XY; Tan YL; Sun YW; Yan GD; Rong YX; Ren QH; Liu JY; Xu XZ; Shan GP; Jin L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Nov; 23(11):661-4. PubMed ID: 22093311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism with fondaparinux.
    Priestley M
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enoxaparin (Clexane), a low molecular weight heparin in preventing thrombosis].
    Jørgensen LN; Hauch O
    Ugeskr Laeger; 1989 Nov; 151(48):3256-8. PubMed ID: 2556826
    [No Abstract]   [Full Text] [Related]  

  • 6. Choosing a parenteral anticoagulant agent.
    Diuguid DL
    N Engl J Med; 2001 Nov; 345(18):1340-2. PubMed ID: 11794155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and treatment of VTE in women with cancer.
    Lee A
    Thromb Res; 2005 Feb; 115 Suppl 1():50-4. PubMed ID: 15790155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)].
    Tablov B; Ruseva A; Tablov V; Popov I; Stoĭkov S
    Akush Ginekol (Sofiia); 2005; 44(5):31-4. PubMed ID: 16313051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice in the perioperative prevention of deep vein thrombosis in german neurosurgical departments: is there a trend towards homogenization?
    Rachinger JC; Koman G; Scheller C; Prell J; Rampp S; Strauss C
    Cent Eur Neurosurg; 2011 Aug; 72(3):115-9. PubMed ID: 21796579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combinative effect of low-molecular-weight heparin and intermittent pneumatic compression device for thrombosis prevention during laparoscopic fundoplication.
    Kiudelis M; Gerbutavicius R; Gerbutaviciene R; Griniūte R; Mickevicius A; Endzinas Z; Pundzius J
    Medicina (Kaunas); 2010; 46(1):18-23. PubMed ID: 20234158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problem of postoperative venous thromboembolic complications in general surgery].
    Kirienko AI; Mishnev OD; Tsitsiashvili MSh; Agafonov VF
    Angiol Sosud Khir; 2003; 9(1):61-5. PubMed ID: 12811394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevention of postoperative deep venous thrombosis in orthopedic surgery].
    Rybachuk OI; Besiedyns'kyĭ SM; Huliaiev DV
    Lik Sprava; 1999 Sep; (6):95-9. PubMed ID: 10626456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism.
    Morris TA; Marsh JJ; Konopka R; Pedersen CA; Chiles PG
    Thromb Res; 2000 Nov; 100(3):185-94. PubMed ID: 11108906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
    Lassen MR; Bauer KA; Eriksson BI; Turpie AG;
    Lancet; 2002 May; 359(9319):1715-20. PubMed ID: 12049858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
    Sherman DG; Albers GW; Bladin C; Fieschi C; Gabbai AA; Kase CS; O'Riordan W; Pineo GF;
    Lancet; 2007 Apr; 369(9570):1347-1355. PubMed ID: 17448820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.